Angiocidin, a tumor-inhibiting novel protein, may also have a role as a new therapeutic application in treating leukemia by inducing a differentiation of monocytic leukemia cells into a normal, macrophage-like phenotype.
Tumor-inhibiting Protein Could Be Effective In Treating LeukemiaCourtesy ScienceDaily Tue, 07/15/2008 - 09:30
Angiocidin, a tumor-inhibiting novel protein, may also have a role as a new therapeutic application in treating leukemia by inducing a differentiation of monocytic leukemia cells into a normal, macrophage-like phenotype. More related itemsPotential New Way To Make A Good Anti-leukemia Drug...
Methadone Breaks Resistance In Untreatable Forms Of...
New Hope For Multiple Sclerosis Sufferers
Vinegar: Over 400 Various, Versatile, and Very Good...
The Complete Idiot's Guide to Chemistry, 2nd Edition...
|
Post new comment